医学
间质性肺病
肺
亚临床感染
放射性武器
放射科
疾病
重症监护医学
病理
内科学
作者
Hiroto Hatabu,Gary M. Hunninghake,Luca Richeldi,Kevin M. Brown,Athol U. Wells,Martine Rémy‐Jardin,Johny Verschakelen,Andrew G. Nicholson,Mary Beth Beasley,David C. Christiani,Raúl San Jośe Estépar,Joon Beom Seo,Takeshi Johkoh,Nicola Sverzellati,Christopher J. Ryerson,R. Graham Barr,Jin Mo Goo,John H. M. Austin,Charles A. Powell,Kyung Soo Lee,Yoshikazu Inoue,David A. Lynch
标识
DOI:10.1016/s2213-2600(20)30168-5
摘要
The term interstitial lung abnormalities refers to specific CT findings that are potentially compatible with interstitial lung disease in patients without clinical suspicion of the disease. Interstitial lung abnormalities are increasingly recognised as a common feature on CT of the lung in older individuals, occurring in 4-9% of smokers and 2-7% of non-smokers. Identification of interstitial lung abnormalities will increase with implementation of lung cancer screening, along with increased use of CT for other diagnostic purposes. These abnormalities are associated with radiological progression, increased mortality, and the risk of complications from medical interventions, such as chemotherapy and surgery. Management requires distinguishing interstitial lung abnormalities that represent clinically significant interstitial lung disease from those that are subclinical. In particular, it is important to identify the subpleural fibrotic subtype, which is more likely to progress and to be associated with mortality. This multidisciplinary Position Paper by the Fleischner Society addresses important issues regarding interstitial lung abnormalities, including standardisation of the definition and terminology; predisposing risk factors; clinical outcomes; options for initial evaluation, monitoring, and management; the role of quantitative evaluation; and future research needs.
科研通智能强力驱动
Strongly Powered by AbleSci AI